BioCentury | Feb 20, 2012
Company News

Cutanea, Maruho deal

...fellow dermatology company Cutanea for an undisclosed sum. Cutanea will become a subsidiary of Maruho. Cutanea...
BioCentury | Oct 31, 2011
Financial News

Cutanea withdraws IPO

...Malvern, Pa. Business: Dermatology Date announced: 10/24/11 Type: IPO Underwriters: Brean Murray; Rodman Note: Cutanea...
BioCentury | Oct 31, 2011
Finance

IPOs on and off

...on and off Cancer vaccine company NewLink Genetics Corp. updated IPO terms, while dermatology play Cutanea Life Sciences Inc....
...cells modified to express alpha 1,3-galactosyltransferase. Underwriters are Stifel Nicolaus Weisel; Canaccord; Baird; and Cantor. Cutanea...
...worldwide rights to the antimicrobial bactolysin peptide from BioWest Therapeutics Inc. (TSX:BWE) for dermatological uses. Cutanea...
BioCentury | Oct 3, 2011
Finance

Cost averaging down

...12/21/10 Up to $86.3M Ph III Taiwan Liposome Co. Ltd. (Taiwan) 9/27/10 TBD Mkt (drug) Cutanea Life Sciences Inc....
BioCentury | Jul 4, 2011
Finance

3Q Financial Markets Preview: Hoping the rally has legs

...9/27/10 TBD Mkt (drug) Quark Pharmaceuticals Inc. (Tel Aviv) 9/24/10 Up to $55M Ph II Cutanea Life Sciences Inc....
BioCentury | Apr 4, 2011
Finance

Hoping for a Springboard

...9/27/10 TBD Mkt (drug) Quark Pharmaceuticals Inc. (Tel Aviv) 9/24/10 Up to $55M Ph II Cutanea Life Sciences Inc....
BioCentury | Jan 3, 2011
Finance

More to life than debt

...Aviv) 9/24/10 Up to $20M Ph II Endocyte Inc. 8/17/10 Up to $86.3M Ph II Cutanea Life Sciences Inc....
BioCentury | Nov 8, 2010
Financial News

Cutanea amends IPO

...to $17.2 million Shares: 2.3 million Price: $6-$7 Underwriters: Brean Murray, Rodman Overallotment: 345,000 Note: Cutanea...
BioCentury | Nov 5, 2010
Financial News

Cutanea sets IPO range

...the company at $25.3 million. In August, Cutanea filed to raise up to $15 million. Cutanea's...
...CLS001 ), is expected to start Phase III testing to treat rosacea in mid-2011. Cutanea...
BioCentury | Nov 1, 2010
Finance

IPO Watch

...IPO watch Dermatology company Cutanea Life Sciences Inc. started on the road last week, with an IPO slated for...
...share. At $6.50, the company would raise $12.7 million and be valued at $21.4 million. Cutanea...
...missed the primary endpoint but met a secondary endpoint in a Phase II rosacea trial. Cutanea...
Items per page:
1 - 10 of 20
BioCentury | Feb 20, 2012
Company News

Cutanea, Maruho deal

...fellow dermatology company Cutanea for an undisclosed sum. Cutanea will become a subsidiary of Maruho. Cutanea...
BioCentury | Oct 31, 2011
Financial News

Cutanea withdraws IPO

...Malvern, Pa. Business: Dermatology Date announced: 10/24/11 Type: IPO Underwriters: Brean Murray; Rodman Note: Cutanea...
BioCentury | Oct 31, 2011
Finance

IPOs on and off

...on and off Cancer vaccine company NewLink Genetics Corp. updated IPO terms, while dermatology play Cutanea Life Sciences Inc....
...cells modified to express alpha 1,3-galactosyltransferase. Underwriters are Stifel Nicolaus Weisel; Canaccord; Baird; and Cantor. Cutanea...
...worldwide rights to the antimicrobial bactolysin peptide from BioWest Therapeutics Inc. (TSX:BWE) for dermatological uses. Cutanea...
BioCentury | Oct 3, 2011
Finance

Cost averaging down

...12/21/10 Up to $86.3M Ph III Taiwan Liposome Co. Ltd. (Taiwan) 9/27/10 TBD Mkt (drug) Cutanea Life Sciences Inc....
BioCentury | Jul 4, 2011
Finance

3Q Financial Markets Preview: Hoping the rally has legs

...9/27/10 TBD Mkt (drug) Quark Pharmaceuticals Inc. (Tel Aviv) 9/24/10 Up to $55M Ph II Cutanea Life Sciences Inc....
BioCentury | Apr 4, 2011
Finance

Hoping for a Springboard

...9/27/10 TBD Mkt (drug) Quark Pharmaceuticals Inc. (Tel Aviv) 9/24/10 Up to $55M Ph II Cutanea Life Sciences Inc....
BioCentury | Jan 3, 2011
Finance

More to life than debt

...Aviv) 9/24/10 Up to $20M Ph II Endocyte Inc. 8/17/10 Up to $86.3M Ph II Cutanea Life Sciences Inc....
BioCentury | Nov 8, 2010
Financial News

Cutanea amends IPO

...to $17.2 million Shares: 2.3 million Price: $6-$7 Underwriters: Brean Murray, Rodman Overallotment: 345,000 Note: Cutanea...
BioCentury | Nov 5, 2010
Financial News

Cutanea sets IPO range

...the company at $25.3 million. In August, Cutanea filed to raise up to $15 million. Cutanea's...
...CLS001 ), is expected to start Phase III testing to treat rosacea in mid-2011. Cutanea...
BioCentury | Nov 1, 2010
Finance

IPO Watch

...IPO watch Dermatology company Cutanea Life Sciences Inc. started on the road last week, with an IPO slated for...
...share. At $6.50, the company would raise $12.7 million and be valued at $21.4 million. Cutanea...
...missed the primary endpoint but met a secondary endpoint in a Phase II rosacea trial. Cutanea...
Items per page:
1 - 10 of 20